AstraZeneca (AZN) and partner Shionogi (SGIOF.PK) have received a boost after Actavis (ACT) unit...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN) and partner Shionogi (SGIOF.PK) have received a boost after Actavis (ACT) unit Watson Laboratories and Egis agreed to drop their attempts to introduce generic versions of AstraZeneca's blockbuster cholesterol drug Crestor until May 2016. The settlement comes after a court upheld the patent on the treatment in December.